REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,330.00
Bid: 12,328.00
Ask: 12,330.00
Change: 212.00 (1.75%)
Spread: 2.00 (0.016%)
Open: 12,244.00
High: 12,336.00
Low: 12,228.00
Prev. Close: 12,118.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

From beer to drugs to cars: Global business laments EU vote

Fri, 24th Jun 2016 06:50

By Ben Hirschler and Martinne Geller

LONDON, June 24 (Reuters) - Shocked chief executives fromMumbai to Denver woke up on Friday to face tough decisions overhow to respond to Britain's vote to leave the European Union.

In Britain itself, businesses as diverse as engineeringgroup Rolls-Royce, drugs giant AstraZeneca, housebuilders and makers of Scotch whisky were braced fordisruption in the short and long term as the pound plunged toits lowest level since 1985.

Big business -- with a very few exceptions -- has beenstrongly in favour of remaining in the world's biggest tradingbloc, primarily because of ease of access to 500 millionEuropean consumers.

"The weeks and months ahead are going to be a nervy time forbusiness leaders," Simon Walker, director general of Britishbusiness lobby the Institute of Directors, said on Friday.

Jaguar Land Rover, Britain's biggest carmaker, has estimatedits annual profit could shrink by 1 billion pounds ($1.4billion) by 2020 if Britain returns to World Trade Organizationrules for trade with Europe.

Shares in the company's owner, India's Tata Motors, slumped more than 10 percent.

Makers of Scotch whisky, who export about 90 percent of whatthey produce, have stressed the importance of the EU, whichswallows about a third of those exports, but also the clout EUmembership gives in negotiations with fast-growing markets suchas India, which has a 150 percent tariff on imported spirits.

Some investors warned of a coming British or even globalrecession as sterling collapsed to hit its lowest since 1985,while FTSE futures fell 8 percent.

The president of Japan's Nippon Steel & Sumitomo Metal, the world's second-largest steelmaker, said the votewas extremely disappointing. "We are greatly concerned for thenegative impact this will have, not only on Britain and the EUbut also on the global economy," said Kosei Shindo.

Martin Sorrell, the boss of the world's biggest advertisinggroup WPP, said: "This decision will create tremendousuncertainty, which will slow economic activity and decisionmaking."

STERLING HEADACHE

Big swings in sterling will be a headache for someinternational companies, with a fall in the currency hittingprofits earned in Britain.

International companies with sizeable sterling exposureinclude Denver-based Molson Coors, owner of Carlingbeer, which is heavily reliant on the UK.

Aside from market access, streamlining of regulations withinthe EU has made life simpler.

Pharmaceutical companies, for example, enjoy a one-stop shopin the form of the European Medicines Agency -- based in London- which approves new drugs for all EU countries, while the EU'sopen airspace deals have fostered a surge in air travel andcommon policies on agriculture and food safety have allowed forsmoother supply chains and richer eating.

Companies in those sectors have fretted that Britain outsidethe bloc would disrupt the regulatory landscape.

"This creates immediate challenges for future investment,research and jobs in our industry in the UK," said MikeThompson, CEO of the Association of the British PharmaceuticalIndustry.

AstraZeneca said it was concerned for the competitiveness ofthe British life sciences industry and would work to ensurepatient access to medicines, amid worries that leaving the EUcould delay drug approvals.

Access to workers is another important factor for companies.Automotive industry executives, who are heavily reliant onexports, ranked tapping a skilled workforce a close second toaccessing EU markets in a survey on reasons to remain in March.

Ahead of the vote, some British-based multinationals such asDiageo, Unilever and Rolls-Royce had expressedtheir support for "Remain" directly to employees, although moststopped short of this.

Government figures show 12.6 percent of Britain's economicoutput is linked to exports to the EU's 27 other members, forwhom only 3.1 percent of output is linked to exports to Britain.And 80 percent of British businesses trading overseas do so withthe EU.

The Confederation of British Industry has estimated therecould be between 550,000 and 950,000 fewer jobs by 2020 in theevent of Brexit.

For banks, a huge concern has been the threat that financialinstitutions based in London could lose their EU "passports", orthe automatic right to sell services across the bloc undersingle low-cost system. That has made bank shares particularlyvolatile in the run-up to the referendum.

Brexit uncertainty has also helped push British merger andacquisition activity this year at its lowest as a proportion ofglobal activity since records began in 1980. ($1 = 0.7428 pounds) (Additional reporting by Kate Holton, Ritsuko Ando and YukaObayashi; Editing by Keith Weir)

More News
16 Jan 2024 17:17

FTSE 100 hits one-month low, precious miners biggest drag

FTSE 100 down 0.5%, FTSE 250 flat

*

Read more
16 Jan 2024 16:17

London close: Stocks finish lower as wage growth eases

(Sharecast News) - London's stock markets finished in the red on Tuesday, as investors assessed the latest UK jobs data.

Read more
16 Jan 2024 11:58

LONDON MARKET MIDDAY: FTSE 100 falls despite cooler UK wage growth

(Alliance News) - The FTSE 100 in London was down at midday Tuesday, as investors nervously eye Wednesday's UK inflation data and what it will mean for interest rates.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.